
OBJECTIVES: Clinical staging has been proposed to improve assessment and treatment planning for personality disorders (PDs) in older adults. This proof-of-concept study examined whether level of personality functioning, assessed with the clinician-rated Level of Personality Functioning Scale - Brief Form 2.0 (LPFS-BF 2.0), might serve as a marker for determining clinical stage in older adults with PDs. METHODS: = .37). CONCLUSIONS: These findings provide preliminary evidence of an association between level of personality dysfunction and clinical stage in older adults with PDs. The pattern suggests a gradual increase in severity across stages, but further research is needed to establish the validity of the staging model.
OBJECTIVES: To establish minimal clinically important difference (MCID) thresholds for the Beck Anxiety Inventory (BAI), Hospital Anxiety and Depression Scale-Anxiety Subscale (HADS-A), Parkinson's Anxiety Scale (PAS), and Geriatric Anxiety Inventory (GAI) in older adults with Parkinson's disease and anxiety (PD-A), and identify optimal thresholds for classifying clinical improvement. METHODS: This cohort study included 110 older adults with PD-A who completed individualized Cognitive-Behavioral Therapy (CBT). Anxiety was assessed before and after intervention using the four scales. Clinical change was anchored to the Global Rating of Change (GRoC) scale. MCIDs were estimated using anchor- and distribution-based methods. RESULTS: Anchor-based between-group mean-change estimates yielded MCIDs of -2.38 (BAI), -3.64 (HADS-A), -3.13 (PAS), and -2.95 (GAI). Receiver operating characteristic analysis using the Youden index identified complementary classification cut-offs of ≤ -2 for the BAI, HADS-A, and PAS, and ≤ -1 for the GAI. CONCLUSIONS: This study provides MCID thresholds for four anxiety measures in older adults with PD-A, offering clinically relevant benchmarks for interpreting treatment-related changes and evaluating improvement. CLINICAL IMPLICATIONS: Clinicians can use the estimated MCID thresholds to interpret whether changes in anxiety scores following CBT are likely to represent clinically meaningful improvement in older adults with PD-A. The complementary ROC-derived cutoffs may assist in identifying individual improvement, while combined use of anxiety measures, particularly the PAS and HADS-A, may enhance sensitivity to clinically meaningful change.
Objectives The high prevalence of neurocognitive disorders in nursing homes highlights the need for non-pharmacological interventions aimed at improving quality of life and psychosocial well-being. This study examines the effects of dramatized reading workshops (the Lulue (R) Method) on quality of life, well-being, loneliness, subjective memory complaints, life satisfaction, and anxiety and depression symptoms among older adults living with neurocognitive disorders. Methods A randomized controlled trial with two parallel groups was conducted among older adults with mild-to-moderate neurocognitive disorders (MMSE < 25/30). Participants were randomly assigned to a weekly Lulue (R) dramatized reading program delivered over three months or a waiting-list control group. Results Significant improvements were observed in the intervention group compared to the control group for quality of life (p = .010), well-being (p = .004), and loneliness (p = .050). No significant differences were found for depressive symptoms or subjective memory complaints. Conclusions These findings support the potential of dramatized reading workshops to enhance psychological well-being among older adults with neurocognitive disorders.Clinical implications Dramatized reading workshops appear to be a feasible, low-cost non-pharmacological intervention that nursing homes could integrate into routine care to support residents' quality of life, well-being, and sense of loneliness.